NCT04416568 2025-12-17Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative CancersDana-Farber Cancer InstitutePhase 2 Active not recruiting45 enrolled
NCT05407441 2025-10-03Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def TumorsDana-Farber Cancer InstitutePhase 1/2 Recruiting49 enrolled